A multicomponent DNA vaccine based on genes encoding proteins of Rhipicephalus microplus salivary proteins induces cross-protective immunity against Rhipicephalus sanguineus infestations in mice and dogs

Author(s)

Elen Anatriello

• Document type: Doctoral Thesis
• Press: Ribeirão Preto.
• Institution: Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (PCARP/BC)
• Defense date: 2012-01-30

Examining board members

Isabel Kinney Ferreira de Miranda Santos; Arlete Aparecida Martins Coelho Castelo; Luiz Ricardo Goulart Filho; Paulo Lee Ho; Celio Lopes Silva

• Advisor: Isabel Kinney Ferreira de Miranda Santos

Abstract

Ticks are arthropod vectors of disease. Vaccines are an alternative to chemicals for controlling ticks because during infestations these parasites stimulate host immune responses such as delayed hypersensitivity skin reactions (DTH), which are involved in their rejection and are correlated with resistance to ticks. Tick salivary glands are important for the parasite to acquire blood meals because their products mediate escape mechanisms from host defenses. The possibility of vaccinating dogs against infestations with the brown dog tick, Rhipicephalus sanguineus, with antigens derived from salivary glands of the cattle tick, R. microplus, was investigated by in silica analysis of 45 genes from R. microplus. These genes were targeted because of their putative biological function and had been cloned into the plasmid vector TOPO VR2001. Of them, 14 were chosen to be evaluated in a vaccine because their sequences were the most similar to several genes expressed in salivary glands of R. sanguineus. The plasmids containing the genes of interest (GIs) were used to assess: 1) The ability of the product of the genes to elicit delayed skin reactions in guinea pigs immune to ticks by previous infestations with R sanguineus. 2) The ability of individual GIs delivered as DNA vaccines to affect infestations of mice with adult R sanguineus. 3) The ability of the genes to induce specific antibodies after vaccination in mice. Only two of the 14 genes delivered to guinea pigs via intradermal injection of DNA did not elicit delayed skin reaction, four used in a vaccine did not affect any parameter of tick infestations, and three did not induce production of antibodies in these animals after DNA vaccination. Of the 14 genes, seven were chosen to formulate a multigene vaccine against the dog tick R. sanguineus. The vaccine was able to significantly affect several parameters of infestations by R sanguineus in vaccinated dogs and mice. This was reflected in the reduction of the number of females that were able to lay eggs, of the average weight of the egg mass produced by these females, of the reproductive rate of these females, and of hatching rate of larvae, demonstrating that GIs from R microplus may be targets for development of a vaccine against the tick R sanguineus. (AU)